Dementia Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Define dementia

A

Progressive, irreversible clinical neurodegenerative syndrome with a range of cognitive and behavioural symptoms e.g. memory loss, problems with reasoning and communication, change in personality, and reduction in person’s ability to carry out daily activities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of dementia

A

Alzheimer’s (70-80%)
Vascular (17%)
Frontotemporal
Lewy body
Parkinson’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What defines early-onset dementia

A

<65yo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the aetiology of Alzheimer’s dementia

A

Formation of senile b-amyloid plaques and neurofibrillary tangles, atrophy of the cerebral cortex

Amyloid: Cleavage by b-secretase (instead of a-secretase) → releases sAPPb (sAPPa) and c99 gragment (c83) → digested by y-secretase → beta-amyloid protein

Tau: hyperphosphorylated → insoluble → aggregates to form neurofibrillary tangles → microtubule instability

Inflammation: increased inflammatory mediators and cytotoxic proteins, increased phagocytosis, decreased neuroprotective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the risk factors for Alzheimer’s

A

Age (1% at 60yo, risk ~doubles every 5 years)
Prior intellectual level (low IQ) or educational level
FHx
Down’s syndrome
Genetic
- Presenilin 1 gene (Chr14)
- Presenilin 2 gene (Chr1)
- Beta-amyloid precursor protein (APP) gene (Chr21)
Cerebrovascular disease, Hyperlipidaemia, Lifestyle (smoking, obesity, high saturated fat diet, alcohol)
Traumatic brain injury
Depression
Elevated plasma homocysteine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the clinical features of Alzheimer’s dementia

A

Gradual and progressive loss in cognitive function
1. memory loss, wandering, irritability
2. 4As
3. Cognitive impairment in all domains, seizures, incontinence, loss of independence

Amnesia
- Recent memory first → loss of episodic memory (recent events, repeated questioning, difficulty with new information)
- misplacing items
- wandering and getting lost
Aphasia
- Broca’s - difficulty finding correct words
- Speech is muddled/disjointed
- Nominal dysphasia
Agnosia
- Typically a visual agnosia e.g. prosopagnosia (recognising faces)
Apraxia
- Typically difficulty with fine motor skills e.g. dressing, skilled tasks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the behavioural and psychological symptoms of dementia (BPSD)

A

Psychosis (delusions and/or hallucinations)
Agitation and emotional lability (easily upset, argumentative, shouting, mood swings)
Depression and anxiety
Withdrawal or apathy
Disinhibition (socially or sexually inappropriate behaviour)
Motor disturbance (wandering, restlessness, pacing, repetitive activity)
Sleep cycle disturbance
Tendency to repeat phrases or questions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What investigations should be done for dementias

A

Collateral history
Full systems exam and obs
Primary care: AMTS, MMSE, MOCA
Secondary: Community assessment form and Addenbrooke’s (ACE-III)

Bedside: BM, urine dip, urine MSU for MC&S, ECG
Bloods: FBC, U&Es, LFTs, TFTs, vitB12 & folate, thiamine, calcium, ESR/CRP, Hba1c, HIV testing and syphilis serology
Other: MRI, CT, FDG-PET
- Alzheimer’s MRI: grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy
- Vascular MRI: multiple white hypodensities
- DLB: generalised atrophy
- FT: frontal and temporal atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management for Alzheimer’s dementia

A

Refer to memory clinic
MDT - Holistic care (proactive and reactive)

Bio
First line: Anticholinesterase - donepezil (aricept), galantamine, rivastigmine
Second line (1st if severe): NMDA/glutamate partial receptor agonist - memantine

Psycho
Structural group cognitive stimulation sessions
Treat co-morbid mental health conditions
Other: Group reminiscence therapy, validation therapy, multisensory therapy

Social
Education for patient and family
Signpost to resources
Optimise other areas of health e.g. vision, hearing and the environment e.g. orientating furniture, staff, dossett boxes
Occupational therapy - rails, changing gas to electric, assistive technology
Carer’s assessment
Meal support
Driving consideration
Sleep hygiene
Planning (advance decisions, LPA, preferred place, wills)

+ 6 months follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the contraindications to using anticholinesterases

A

Must do an ECG before starting acetylcholinesterase
Absolute contraindications:
- Anticholinergics
- Beta-blockers
- NSAIDs
- Muscle relaxants

Relative CIs: Asthma, COPD, GI disease, bradycardia, sick sinus syndrome, AV block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the management for patients with dementia who are at risk of harming themselves or experiencing agitation/hallucinations/delusion

A

De-escalation strategies
Risperidone and haloperidol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the side effects of anticholinesterases

A

GI issues e.g. Nausea, vomiting, diarrhoea, anorexia
Fatigue
Dizziness
Headache
Insomnia
Muscle cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the prognosis for Alzheimer’s dementia

A

Average life expectancy from diagnosis is 3-8 weeks
Good prognostic indicator: female
Bad prognostic indicator: male, depression, behavioural problems, severe focal cognitive deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the aetiology and risk factors for vascular dementia

A

Infarcts caused by thromboemboli or narrowing of arteries due to HTN

RF:
Age
Male
Obesity
Lack of exercise
Smoking
AF
DM
HTN
CVA history (stroke, TIA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical features of vascular dementia

A

Sudden onset (may follow CVA), stepwise deterioration
- 1st: emotional and minor personality changes (labile emotion – tearful elation)
- 2nd: cognitive deficit
Focal neurological signs (S/S reflect site of infarct) – i.e. upgoing plantars, hemiparesis, visual field defects
Gait an attention problems (subcortical ischaemic vascular)
Co-morbid depression
Relatively preserved personality e.g. in AD “mum just isn’t herself anymore” vs in VD “mum is a little different and is using her left arm much less”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the management for vascular dementia

A

Refer to memory clinic
MDT (esp. psychiatrist, social working, neuropsychologist)

Bio
Daily aspirin
Reduce risk factors: stop alcohol, treat HTN, treat AF, control DM)

Psycho
Structural Group Cognitive Stimulation sessions
exclude depression of GAD
Other: Group reminiscence therapy, validation therapy, multisensory therapy

Social
Education for patient and family
Signpost to resources
Optimise other areas of health e.g. vision, hearing and the environment e.g. orientating furniture, staff, dossett boxes
SALT, physiotherapy
Occupational therapy - rails, changing gas to electric, assistive technology
Carer’s assessment
Meal support
Driving consideration
Sleep hygiene
Planning (advance decisions, LPA, preferred place, wills)

+ 6 months follow up

17
Q

What is the aetiology of Dementia with Lewy Bodies

A

Lewy Bodies (LB) = a-synuclein with ubiquitin
Spectrum of diseases including Lewy Bodies = DLB and Parkinson’s disease (PD)

In DLB, LB are found in the brainstem, cingulate gyrus and neocortex (Dementia first)
In PD, LB are found in the brainstem (Parkinsonism first)

18
Q

What are the signs and symptoms of dementia with Lewy Bodies

A
  1. Fluctuating confusion with marked variations in alertness levels (may resemble delirium)
    - has some lucid intervals (unlike other dementias)
  2. Vivid visual hallucinations (Lilliputian hallucinations) – animals or humans - typically “small people”
  3. Parkinsonism (shuffling gait, bradykinesia, rigidity, amimia)

+ anosmia (early sign)
+ frequent falls
± depression

19
Q

What is the management for dementia with Lewy Bodies

A

MDT

Bio
First line: Anticholinesterases (donepezil, rivastigmine)

Psycho
Structural Group Cognitive Stimulation sessions
exclude depression of GAD
Other: Group reminiscence therapy, validation therapy, multisensory therapy

Social
Education for patient and family
Signpost to resources
Optimise other areas of health e.g. vision, hearing and the environment e.g. orientating furniture, staff, dossett boxes
SALT, physiotherapy
Occupational therapy - rails, changing gas to electric, assistive technology
Carer’s assessment
Meal support
Driving consideration
Sleep hygiene
Planning (advance decisions, LPA, preferred place, wills)

+ 6 months follow up

20
Q

What is the cause of frontotemporal dementia

A

atrophy of fronto-temporal regions
60% sporadic; 40% autosomal inheritance

Tau positive – “Pick’s” bodies (hyperphosphorylated tau) = Pick’s disease (3R), CBD (4R), PSP (4R)
Tau negative – no Tau = FTLD-U (Frontotemporal Lobar Dementia with Ubiquinated inclusions)

21
Q

What are the clinical features of frontotemporal dementia

A

(1) Frontal lobe syndrome: disinhibition, social/personality changes
(2) Semantic dementia → progressive loss of understanding of verbal and visual meaning
(3) Progressive non-fluent aphasia: 1st: naming difficulties; 2nd: mutism

(Memory tends to be affected much later)

22
Q

What is the management for fronto-temporal dementia

A

Refer to memory clinic
MDT

Bio
Mood impairment: Antidepressants

Psycho
Structural Group Cognitive Stimulation sessions
exclude depression of GAD
Other: Group reminiscence therapy, validation therapy, multisensory therapy

Social
Education for patient and family
Signpost to resources
Optimise other areas of health e.g. vision, hearing and the environment e.g. orientating furniture, staff, dossett boxes
SALT, physiotherapy
Occupational therapy - rails, changing gas to electric, assistive technology
Carer’s assessment
Meal support
Driving consideration
Sleep hygiene
Planning (advance decisions, LPA, preferred place, wills)

+ 6 months follow up

23
Q

What are the differentials for dementia

A

Normal age-related memory changes
Mild cognitive impairment
Depression
Delirium
Thiamine deficiency
Vit B12 deficiency
Hypothyroidism
Medication (Benzos, opioids, anticholinergics, antiepileptics)
Normal pressure hydrocephalus

24
Q

Describe the psychological therapies used in dementias

A

Cognitive stimulation therapy = a range of activities and discussions (usually in a group) that are aimed at general improvement of cognitive and social functioning

Group reminiscence therapy - uses objects from daily life to stimulate memory and enable people to value their experiences

Cognitive rehabilitation or occupational therapy to support functional ability — the aim is to addresses the disability resulting from the impact of cognitive impairment on everyday functioning and activity by identifying goals that are relevant to the person

25
Q

What are the considerations for end-stage dementia

A

Eating and drinking
- Loss of weight can occur in the later stages of dementia because of difficulties with coordination, chewing and swallowing, and/or inability or unwillingness to eat
- Encourage people with dementia to eat and drink for as long as possible
- Consider involving SALT or dietician if there are concerns

Distress or changes in behaviour
- Assess the person for a clinical or environmental cause e.g. pain, delirium

Constipation, nausea, loss of appetite
- Consider stopping any opioids
Resuscitation

  • Cardiopulmonary resuscitation is unlikely to succeed in cases of cardiopulmonary arrest in people with severe dementia.
26
Q

What are the scoring thresholds for dementia questionnaires

A

AMTS (score <7 = cog impairment)
GP Assessment of Cognition (or 6 Item OT)
MMSE
- Mild Alzheimer’s: 21-26
- Moderate Alzheimer’s: 10-20
- Severe Alzheimer’s: < 10
MOCA <26
RUDAS (22/30)
Addenbrooke’s cognition examination (ACE III) (attention, memory, fluency, language, visuospatial)
- <88 = mild cognitive impairment
- <82 = suspected dementia